The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...
Eli Lilly and Company LLY announced that the FDA has granted approval to its IL-13 inhibitor Ebglyss (lebrikizumab) for ...
Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...
Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...
Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...
This is not a drill—score up to 50% off everything from Banana Republic’s Outlet, plus an extra 20% off fall styles for a limited time only. The 2024 Lilly Pulitzer Sunshine Sale just got even ...
Brief synopsis and analysis of news items that are affecting the equities market. Intuitive Machines rockets to another planet after winning a $4.82 bln NASA contract (LUNR) Intuitive Machines (LUNR ...